Friday, October 9, 2020 (10:00am PT/1:00pm ET)
This webinar is presented by:
Part of the 2020 Technical Symposium
[Please Note: This webinar will be free for all SCC Members to attend. Members should have received an email with a direct link to the registration page for the webinar. If you are a member and did not receive an email, please contact us at firstname.lastname@example.org]
Silicones have been used in medical and cosmetic applications for over 60 years. Polydimethylsiloxanes are primary silicone polymers that are typically used as excipients in topical and transdermal drug products in delivering drug to or through the skin. Inherent characteristics like hydrophobicity, low surface tension, polymer chain flexibility, and low intermolecular interaction allow silicones to offer function and performance to drug products. Silicone pressure sensitive adhesives demonstrated their efficacy and performance in transdermal drug delivery as evidenced by the number of commercial transdermal patch products in the market. Recent technologies like swollen crosslinked silicone elastomer blend networks and silicone-acrylic hybrid pressure sensitive adhesives promise potential performance advantages and improved drug delivery efficacy. This presentation provides an overview of several types of silicone technologies and their function as excipients enabling efficient drug delivery for skin.
WHO SHOULD ATTEND:
This webinar is open to all SCC members.
Dr. Hyder Aliyar
Hyder is working as a Research Investigator in the Medical Silicones group of Transportation and Industrial division in DuPont. At work, his focus is to investigate and evaluate silicone technologies to product development for drug delivery and skin care. Design and development of efficient drug delivery formulations for skin is one of his key interests. He has a PhD in Polymer Science from University of Madras, India. For the last 20+ years, he has gained research and product development experience via working in research institutes, universities and industry both in Japan and US, all almost on polymeric materials for medical device and drug delivery. Prior to DuPont, he was at Dow Corning and subsequently at Dow.